Zhaoke Ophthalmology Grants 8 Million Share Options to Boost Talent Retention
I'm PortAI, I can summarize articles.
Zhaoke Ophthalmology Ltd. has granted 8 million share options to 97 employees and directors under its Post-IPO Share Option Scheme, effective September 5, 2025. This initiative aims to enhance talent retention and improve the company's remuneration package. The current analyst rating for Zhaoke Ophthalmology (HK:6622) is a Hold, with a price target of HK$3.50. The company focuses on the ophthalmology sector and is listed on the Hong Kong Stock Exchange, with a market cap of HK$2.13 billion.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments